Clinical Research Directory
Browse clinical research sites, groups, and studies.
SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters
Sponsor: Luzerner Kantonsspital
Summary
The purpose of the SIROOP Registry is to retrospectively and prospectively collect baseline, clinical and procedural characteristics of patients who have undergone PCI and are treated with either currently available sirolimus or paclitaxel coated DCBs (see Table 1), irrespective of clinical presentation as well as to prospectively collect data about their clinical outcomes. Outcomes will be compared in different clinical subgroups. The impact of current DCBs in different clinical settings and coronary artery lesions on cardiovascular outcomes will be assessed.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2021-06-01
Completion Date
2031-12-31
Last Updated
2024-10-29
Healthy Volunteers
No
Conditions
Interventions
Sirolimus Eluting Balloon
PTCA with either a Sirolimus eluting balloon or Paclitaxel eluting balloon
Locations (1)
Luzerner Heart Centre
Lucerne, Canton of Lucerne, Switzerland